Analysts anticipate Turning Point Brands to report an earnings per share (EPS) of $0.75. Turning Point Brands bulls will hope ...

Analysts expect Sarepta Therapeutics to report an earnings per share (EPS) of $1.01. The announcement from Sarepta ...

Price Targets: Analysts navigate through adjustments in price targets, providing estimates for SolarEdge Technologies's ...

Analysts are estimating that Travere Therapeutics will report an earnings per share (EPS) of $-0.12. The announcement from ...

Shares of JPMorgan Chase & Co. (NYSE: JPM) and Bank of America Inc. (NYSE: BAC) are trading lower Tuesday after President ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $74.61, a high estimate of $90.00, ...

The surge of companies adding cryptocurrencies to their balance sheets may be hitting a plateau, according to Galaxy Digital ...

Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved ...

In connection with earnings, Vertex announced topline results from the Phase 2 study evaluating the safety and efficacy of VX ...

ZetaChain's (CRYPTO: ZETA) latest integration with the Sui (CRYPTO: SUI) blockchain could bring real capital flows and ...

Shift4 Payments (FOUR) stock falls on lower-than-expected Q2 results. Revenue growth of 17% missed estimate, adjusted EPS ...

Vertex stock falls after pain drug VX-993 fails Phase 2 trial, despite better-than-expected Q2 earnings and strong cystic ...